Skip to main content
Log in

Biosensor-based small molecule fragment screening with biolayer interferometry

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

Biosensor-based fragment screening is a valuable tool in the drug discovery process. This method is advantageous over many biochemical methods because primary hits can be distinguished from non-specific or non-ideal interactions by examining binding profiles and responses, resulting in reduced false-positive rates. Biolayer interferometry (BLI), a technique that measures changes in an interference pattern generated from visible light reflected from an optical layer and a biolayer containing proteins of interest, is a relatively new method for monitoring small molecule interactions. The BLI format is based on a disposable sensor that is immersed in 96-well or 384-well plates. BLI has been validated for small molecule detection and fragment screening with model systems and well-characterized targets where affinity constants and binding profiles are generally similar to those obtained with surface plasmon resonsance (SPR). Screens with challenging targets involved in protein–protein interactions including BCL-2, JNK1, and eIF4E were performed with a fragment library of 6,500 compounds, and hit rates were compared for these targets. For eIF4E, a protein containing a PPI site and a nucleotide binding site, results from a BLI fragment screen were compared to results obtained in biochemical HTS screens. Overlapping hits were observed for the PPI site, and hits unique to the BLI screen were identified. Hit assessments with SPR and BLI are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Congreve M, Rich R, Myszka D, Figaroa F, Siegal G, Marshall F (2011) In: Kuo L (ed) Methods in enzymology, 493, fragment-based drug design- tools, practical approaches, and examples. Elsevier, Amsterdam

    Google Scholar 

  2. Giannetti M (2011) In: Kuo L (ed) Methods in enzymology, 493, fragment-based drug design- tools, practical approaches, and examples. Elsevier, Amsterdam

  3. Geitmann M, Elinder M, Seeger C, Brandt P, de Esch IJP, Danielson UH (2011) J Med Chem 54:699–708

    Article  CAS  Google Scholar 

  4. Navratilova I, Hopkins AL (2010) ACS Med Chem Lett 1:44–48

    Article  CAS  Google Scholar 

  5. Perspicace S, Banner D, Benz J, Müller F, Schlatter D, Huber W (2009) J Biomol Screen 14(4):337–349

    Article  CAS  Google Scholar 

  6. Antonysamy SS, Aubol B, Blaney J, Browner MF, Giannetti AM, Harris SF, Hébert N, Hendle J, Hopkins S, Jefferson E, Kisinger C, Leveque V, Marciano D, McGee E, Nájera I, Nolan B, Tomimoto M, Torres E, Wright T (2008) Biorg Med Chem Lett 18:2990–2995

    Article  CAS  Google Scholar 

  7. Hämäläinen MD, Zhukov A, Ivarsson M, Fex T, Gottfries J, Karlsson R, Björsne M (2008) J Biomol Screen 13(3):202–209

    Article  Google Scholar 

  8. Nordström H, Gossas T, Hämäläinen M, Källblad P, Nyström S, Wallberg H, Danielson UH (2008) J Med Chem 51:3449–3459

    Article  Google Scholar 

  9. Giannetti AM, Koch BD, Browner MF (2008) J Med Chem 51:574–580

    Article  CAS  Google Scholar 

  10. Arkin MR, Wells JA (2004) Nat Rev Drug Discov 3:301–317

    Article  CAS  Google Scholar 

  11. Hajduk PH, Greer J (2007) Nat Rev Drug Discov 6:211–219

    Article  CAS  Google Scholar 

  12. Murray CW, Carr MG, Callaghan O, Chessari G, Congreve M, Cowan S, Coyle JE, Downham R, Figueroa E, Frederickson M, Graham B, McMenamin R, O’Brien MA, Patel S, Phillips TR, Williams G, Woodhead AJ, Woolford A (2010) J Med Chem 53:5942–5955

    Article  CAS  Google Scholar 

  13. Barelier S, Pons J, Marcillat O, Lancelin J-M, Krimm I (2010) J Med Chem 53:2577–2588

    Article  CAS  Google Scholar 

  14. Martin E, Wang J, Zaror I, Yu J, Yan K, Doyle M, Feucht P, Shoemaker K, Warne B, Chin M, Blisseth S, Leder L, Meyerhofer M, Wartchow C, Yao D (2011) In: Cooper M (ed) and Mayr LM (co-ed) Label-free technologies for drug discovery. Wiley

  15. Myszka DG (2004) Anal Biochem 329:316–323

    Article  CAS  Google Scholar 

  16. Wartchow C, Yao D, Li P, Heidecker B, Wei J, Choo S, Zuk R (2008) Society for Biochemical sciences annual meeting, St. Louis, Poster P2072

  17. Papalia GA, Leavitt S, Bynum MA, Katsamba PS, Wilton R, Qiu H, Steukers M, Want S, Bindu L, Phogat S, Giannetti AM, Ryan TE, Pudlak VA, Matusiewicz K, Michelson KM, Nowakowski A, Pham-Baginski A, Brooks J, Tieman BC, Bruce BD, Vaughn M, Baksh M, Cho YH, De Wit M, Smets A, Vandersmissen J, Michiels L, Myszka DG (2006) Anal Biochem 359:94–105

    Article  CAS  Google Scholar 

  18. Podlaski F, Wartchow C, Gao L, Li S, Walker S, Ibabecki S, Huang K-S, Mark D (2010) Society for biochemical sciences annual meeting, Phoenix, Poster B209

  19. Wartchow C, Yao D, Chen J, Ho H, Ikin B, Perillat D, Wicke R, Witte, Zhao L-Z (2010) Society for biochemical sciences annual meeting, Phoenix, Poster B271

  20. Youle RJ, Strasser A (2008) Nat Rev Mol Cell Biol 9:47–59

    Article  CAS  Google Scholar 

  21. Blagden SP, Willis AE (2011) Nat Rev Clin. Onc advanced on-line publication. doi: 10.1038/nrclinonc2011.16

  22. Comess KM, Sun C, Abad-Zapatero C, Goedken ER, Gum RJ, Borhani DW, Argiriadi M, Groebe DR, Jia Y, Clampit JE, Haasch DL, Smith HG, Wang S, Song D, Coen ML, Cloutier TE, Tang H, Cheng X, Quinn C, Liu B, Xin Z, Liu G, Fry EH, Stoll V, Ng TI, Banach D, Marcotte D, Burns DJ, Calderwood DJ, Hadjuk PJ (2011) ACS Chem Biol 6:234–244

    Article  CAS  Google Scholar 

  23. Beckett D, Kovaleva E, Schatz J (1999) Prot Sci 8(4):921–929

    Article  CAS  Google Scholar 

  24. Papalia G, Myszka D (2010) Anal Biochem 403:30–35

    Article  CAS  Google Scholar 

  25. Fesik SW (2005) Nat Rev Cancer 5:876–885

    Article  CAS  Google Scholar 

  26. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, Swift K, Matayoshi ED, Oltersdorf T, Fesik SW (2001) PNAS 98(6):3012–3017

    Article  CAS  Google Scholar 

  27. Ku B, Liang C, Jung JU, Oh B-H (2010) Cell Res. doi: 10.1038/cr.2010.149

  28. Niedzwieka A, Marcotrigiano J, Stepinski J, Jankowska-Anyszka M, Wyslouch-Cieszynska A, Dadlez M, Gingras A-C, Mak P, Darzynkiewicz E, Sonenberg N, Burley SK, Stolarski R (2002) J Mol Biol 319:615–635

    Article  Google Scholar 

  29. Coan KED, Shoichet BK (2008) J Am Chem Soc 130:9606–9612

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Huifeng Niu for guidance in eIF4E biology, the Roche Nutley protein group including Linda Reik, Colin Garvie, and Dave Weber for assistance with proteins and protein chemistry, the structure group and chemistry groups including David Fry and Paul Gillespie for assistance with fragment structure, test libraries, and chemistry, Yang Wen for assistance with solubility studies, Steve Ferguson and Samir Serrano for the LC/MS purity studies, and Janet Diratsaoglu, Peggy Borgese, and Sevan Ibabecki for assistance with compounds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles A. Wartchow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wartchow, C.A., Podlaski, F., Li, S. et al. Biosensor-based small molecule fragment screening with biolayer interferometry. J Comput Aided Mol Des 25, 669–676 (2011). https://doi.org/10.1007/s10822-011-9439-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-011-9439-8

Keywords

Navigation